Skip to main content

Table 1 Baseline characteristics according to the multimorbidity clusters

From: Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention: latent class analysis of the Melbourne Interventional Group (MIG) registry

 

A

(n = 5912, 42%)

B

(n = 853, 6%)

C

(n = 553, 4%)

D

(n = 6707, 48%)

Total (n = 14,025)

Age, years, mean ± SD

65.1 ± 11.3

71.8 ± 12.0

71.1 ± 10.8

60.1 ± 11.8

63.3 ± 12.1

Male, n (%)

4121 (69.7)

542 (63.5)

340 (61.5)

5402 (80.5)

10,405 (74.2)

Multimorbidity, n (%)

     

Hypertension

5782 (97.9)

624 (73.3)

520 (94.4)

1308 (19.5)

8234 (58.8)

Dyslipidaemia

5414 (91.8)

12 (1.4)

482 (87.5)

2419 (36.1)

8327 (59.5)

Diabetes

1868 (31.6)

62 (7.3)

406 (73.4)

472 (7.0)

2808 (20.0)

Cerebrovascular disease

411 (7.0)

69 (8.1)

167 (30.3)

29 (0.4)

676 (4.8)

PVD

241 (4.1)

46 (5.4)

199 (36.1)

57 (0.9)

543 (3.9)

Reduced EF

831 (14.1)

442 (51.8)

311 (56.2)

1274 (19.0)

2858 (20.4)

Reduced eGFR

1143 (19.3)

756 (88.6%)

469 (84.8)

466 (6.9)

2834 (20.2)

Chronic lung disease

600 (10.2)

154 (18.1)

124 (22.4)

452 (6.7)

1347 (9.6)

OSA

292 (4.9)

2 (0.2)

51 (9.2)

91 (1.4)

436 (3.1)

Number of multimorbidity, mean ± SD

3 ± 1

3 ± 1

5 ± 1

1 ± 1

2 ± 1

Admission status, n (%)

     

Elective

1910 (32.3)

106 (12.4)

127 (23.0)

1042 (15.5)

3181 (22.7)

Urgent/rescue

4002 (67.7)

747 (87.6)

426 (77.0)

5665 (84.5)

10,840 (77.3)

Cardiac status at admission, n (%)

     

ACS

4044 (68.5)

749 (88.0)

427 (77.2)

5699 (85.0)

10,919 (77.9)

STEMI

1650 (27.9)

523 (61.3)

222 (40.1)

(3277 (48.9)

5671 (40.4)

Cardiogenic shock

124 (2.1)

146 (17.1)

74 (13.4)

228 (3.4)

572 (4.1)

Multi-lesion PCI procedure, n (%)

1594 (27.0)

264 (30.9)

191 (34.5)

1569 (23.4)

3618 (25.8)

  1. SD: Standard Deviation; STEMI: ST elevated myocardial infarction; ACS: Acute coronary syndrome; PCI: percutaneous coronary intervention, PVD: peripheral vascular disease, EF: ejection fraction, eGFR: estimated glomerular filtration rate, OSA: obstructive sleep apnoea